fashion -WSS

fashion

author：knowledge 2025-10-02 22:24:04 - browse：932

Adderall XR capsules are displayed on Feb. 24, 2023. Drug shortages are growing in the United States, and experts see no clear path to resolving them. – health care policy coverage from STAT — Medicare has a new proposal to pay hospitals more to stockpile essential drugs, an effort to avoid shortages of chemotherapies and other drugs. Jenny Kane/AP

WASHINGTON — Medicare has a new proposal to pay hospitals more to stockpile essential drugs — an idea that comes as doctors report running low on critical chemotherapies and other drugs. But experts caution the policy could cause the very shortages that government officials are trying to avoid.

For years most of the solutions for addressing drug shortages have involved giving the Food and Drug Administration more power. During the Covid-19 pandemic, Congress empowered the FDA to make drug companies create backup plans for manufacturing facility interruptions, and to collect information from drug makers on where they source ingredients. The FDA also has the authority to prioritize reviews of applications for drugs in short supply and to prioritize inspections of manufacturing facilities that plan to ramp up production.

But Medicare has its own new idea: paying hospitals to create a “buffer stock” of 86 medicines that HHS deems critical. Medicare would not pay hospitals for the drugs. Rather, it would pay hospitals for the cost of managing a three-month inventory of the drugs. It published the proposal in a rule last week; it’s seeking comment now before it will weigh whether to finalize the policy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： New details revealed about Purdue's marketing of OxyContin

WSS

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Liz Cheney makes 1st public comment since Trump's election interference indictments

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

focus

fashion

knowledge

Sports medicine is finally prioritizing gender equality

Listen: More tumult at BIO & coercive care for sickle cell patients

In Memoriam: Notable people who died in 2023

Liver decline slowed by off

Affirmative action in medical school literally saved lives

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

The cancer drug shortage isn’t new — and neither are the solutions

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

Peter Hotez and the public health issue of online harassment

Listen: A conversation with researcher Kevin Esvelt on biosecurity

leisure time

FDA approves first treatment for ultra

As a primary care physician, here's how I hope to partner with AI

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Clinical trials must include more disabled people

FDA approves first treatment for ultra

Living with Hashimoto's and celiac disease, and med school, too

entertainment

focus

knowledge

explore